Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers
In cancer many gene variants may contribute to disease etiology, but the impact of a given gene variant may have varied effect size. Here, the authors analyse summary statistics of genome-wide association studies from fourteen cancers, and show the utility of polygenic risk scores may vary depending...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-07-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-16483-3 |
id |
doaj-043bfd656ef148a0993f50953c04b25f |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yan Dora Zhang Amber N. Hurson Haoyu Zhang Parichoy Pal Choudhury Douglas F. Easton Roger L. Milne Jacques Simard Per Hall Kyriaki Michailidou Joe Dennis Marjanka K. Schmidt Jenny Chang-Claude Puya Gharahkhani David Whiteman Peter T. Campbell Michael Hoffmeister Mark Jenkins Ulrike Peters Li Hsu Stephen B. Gruber Graham Casey Stephanie L. Schmit Tracy A. O’Mara Amanda B. Spurdle Deborah J. Thompson Ian Tomlinson Immaculata De Vivo Maria Teresa Landi Matthew H. Law Mark M. Iles Florence Demenais Rajiv Kumar Stuart MacGregor D. Timothy Bishop Sarah V. Ward Melissa L. Bondy Richard Houlston John K. Wiencke Beatrice Melin Jill Barnholtz-Sloan Ben Kinnersley Margaret R. Wrensch Christopher I. Amos Rayjean J. Hung Paul Brennan James McKay Neil E. Caporaso Sonja I. Berndt Brenda M. Birmann Nicola J. Camp Peter Kraft Nathaniel Rothman Susan L. Slager Andrew Berchuck Paul D. P. Pharoah Thomas A. Sellers Simon A. Gayther Celeste L. Pearce Ellen L. Goode Joellen M. Schildkraut Kirsten B. Moysich Laufey T. Amundadottir Eric J. Jacobs Alison P. Klein Gloria M. Petersen Harvey A. Risch Rachel Z. Stolzenberg-Solomon Brian M. Wolpin Donghui Li Rosalind A. Eeles Christopher A. Haiman Zsofia Kote-Jarai Fredrick R. Schumacher Ali Amin Al Olama Mark P. Purdue Ghislaine Scelo Marlene D. Dalgaard Mark H. Greene Tom Grotmol Peter A. Kanetsky Katherine A. McGlynn Katherine L. Nathanson Clare Turnbull Fredrik Wiklund Breast Cancer Association Consortium (BCAC) Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON) Colon Cancer Family Registry (CCFR) Transdisciplinary Studies of Genetic Variation in Colorectal Cancer (CORECT) Endometrial Cancer Association Consortium (ECAC) Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) Melanoma Genetics Consortium (GenoMEL) Glioma International Case-Control Study (GICC) International Lung Cancer Consortium (ILCCO) Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium International Consortium of Investigators Working on Non-Hodgkin’s Lymphoma Epidemiologic Studies (InterLymph) Ovarian Cancer Association Consortium (OCAC) Oral Cancer GWAS Pancreatic Cancer Case-Control Consortium (PanC4) Pancreatic Cancer Cohort Consortium (PanScan) Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL) Renal Cancer GWAS Testicular Cancer Consortium (TECAC) Stephen J. Chanock Nilanjan Chatterjee Montserrat Garcia-Closas |
spellingShingle |
Yan Dora Zhang Amber N. Hurson Haoyu Zhang Parichoy Pal Choudhury Douglas F. Easton Roger L. Milne Jacques Simard Per Hall Kyriaki Michailidou Joe Dennis Marjanka K. Schmidt Jenny Chang-Claude Puya Gharahkhani David Whiteman Peter T. Campbell Michael Hoffmeister Mark Jenkins Ulrike Peters Li Hsu Stephen B. Gruber Graham Casey Stephanie L. Schmit Tracy A. O’Mara Amanda B. Spurdle Deborah J. Thompson Ian Tomlinson Immaculata De Vivo Maria Teresa Landi Matthew H. Law Mark M. Iles Florence Demenais Rajiv Kumar Stuart MacGregor D. Timothy Bishop Sarah V. Ward Melissa L. Bondy Richard Houlston John K. Wiencke Beatrice Melin Jill Barnholtz-Sloan Ben Kinnersley Margaret R. Wrensch Christopher I. Amos Rayjean J. Hung Paul Brennan James McKay Neil E. Caporaso Sonja I. Berndt Brenda M. Birmann Nicola J. Camp Peter Kraft Nathaniel Rothman Susan L. Slager Andrew Berchuck Paul D. P. Pharoah Thomas A. Sellers Simon A. Gayther Celeste L. Pearce Ellen L. Goode Joellen M. Schildkraut Kirsten B. Moysich Laufey T. Amundadottir Eric J. Jacobs Alison P. Klein Gloria M. Petersen Harvey A. Risch Rachel Z. Stolzenberg-Solomon Brian M. Wolpin Donghui Li Rosalind A. Eeles Christopher A. Haiman Zsofia Kote-Jarai Fredrick R. Schumacher Ali Amin Al Olama Mark P. Purdue Ghislaine Scelo Marlene D. Dalgaard Mark H. Greene Tom Grotmol Peter A. Kanetsky Katherine A. McGlynn Katherine L. Nathanson Clare Turnbull Fredrik Wiklund Breast Cancer Association Consortium (BCAC) Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON) Colon Cancer Family Registry (CCFR) Transdisciplinary Studies of Genetic Variation in Colorectal Cancer (CORECT) Endometrial Cancer Association Consortium (ECAC) Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) Melanoma Genetics Consortium (GenoMEL) Glioma International Case-Control Study (GICC) International Lung Cancer Consortium (ILCCO) Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium International Consortium of Investigators Working on Non-Hodgkin’s Lymphoma Epidemiologic Studies (InterLymph) Ovarian Cancer Association Consortium (OCAC) Oral Cancer GWAS Pancreatic Cancer Case-Control Consortium (PanC4) Pancreatic Cancer Cohort Consortium (PanScan) Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL) Renal Cancer GWAS Testicular Cancer Consortium (TECAC) Stephen J. Chanock Nilanjan Chatterjee Montserrat Garcia-Closas Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers Nature Communications |
author_facet |
Yan Dora Zhang Amber N. Hurson Haoyu Zhang Parichoy Pal Choudhury Douglas F. Easton Roger L. Milne Jacques Simard Per Hall Kyriaki Michailidou Joe Dennis Marjanka K. Schmidt Jenny Chang-Claude Puya Gharahkhani David Whiteman Peter T. Campbell Michael Hoffmeister Mark Jenkins Ulrike Peters Li Hsu Stephen B. Gruber Graham Casey Stephanie L. Schmit Tracy A. O’Mara Amanda B. Spurdle Deborah J. Thompson Ian Tomlinson Immaculata De Vivo Maria Teresa Landi Matthew H. Law Mark M. Iles Florence Demenais Rajiv Kumar Stuart MacGregor D. Timothy Bishop Sarah V. Ward Melissa L. Bondy Richard Houlston John K. Wiencke Beatrice Melin Jill Barnholtz-Sloan Ben Kinnersley Margaret R. Wrensch Christopher I. Amos Rayjean J. Hung Paul Brennan James McKay Neil E. Caporaso Sonja I. Berndt Brenda M. Birmann Nicola J. Camp Peter Kraft Nathaniel Rothman Susan L. Slager Andrew Berchuck Paul D. P. Pharoah Thomas A. Sellers Simon A. Gayther Celeste L. Pearce Ellen L. Goode Joellen M. Schildkraut Kirsten B. Moysich Laufey T. Amundadottir Eric J. Jacobs Alison P. Klein Gloria M. Petersen Harvey A. Risch Rachel Z. Stolzenberg-Solomon Brian M. Wolpin Donghui Li Rosalind A. Eeles Christopher A. Haiman Zsofia Kote-Jarai Fredrick R. Schumacher Ali Amin Al Olama Mark P. Purdue Ghislaine Scelo Marlene D. Dalgaard Mark H. Greene Tom Grotmol Peter A. Kanetsky Katherine A. McGlynn Katherine L. Nathanson Clare Turnbull Fredrik Wiklund Breast Cancer Association Consortium (BCAC) Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON) Colon Cancer Family Registry (CCFR) Transdisciplinary Studies of Genetic Variation in Colorectal Cancer (CORECT) Endometrial Cancer Association Consortium (ECAC) Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) Melanoma Genetics Consortium (GenoMEL) Glioma International Case-Control Study (GICC) International Lung Cancer Consortium (ILCCO) Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium International Consortium of Investigators Working on Non-Hodgkin’s Lymphoma Epidemiologic Studies (InterLymph) Ovarian Cancer Association Consortium (OCAC) Oral Cancer GWAS Pancreatic Cancer Case-Control Consortium (PanC4) Pancreatic Cancer Cohort Consortium (PanScan) Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL) Renal Cancer GWAS Testicular Cancer Consortium (TECAC) Stephen J. Chanock Nilanjan Chatterjee Montserrat Garcia-Closas |
author_sort |
Yan Dora Zhang |
title |
Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers |
title_short |
Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers |
title_full |
Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers |
title_fullStr |
Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers |
title_full_unstemmed |
Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers |
title_sort |
assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers |
publisher |
Nature Publishing Group |
series |
Nature Communications |
issn |
2041-1723 |
publishDate |
2020-07-01 |
description |
In cancer many gene variants may contribute to disease etiology, but the impact of a given gene variant may have varied effect size. Here, the authors analyse summary statistics of genome-wide association studies from fourteen cancers, and show the utility of polygenic risk scores may vary depending on cancer type. |
url |
https://doi.org/10.1038/s41467-020-16483-3 |
work_keys_str_mv |
AT yandorazhang assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT ambernhurson assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT haoyuzhang assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT parichoypalchoudhury assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT douglasfeaston assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT rogerlmilne assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT jacquessimard assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT perhall assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT kyriakimichailidou assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT joedennis assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT marjankakschmidt assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT jennychangclaude assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT puyagharahkhani assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT davidwhiteman assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT petertcampbell assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT michaelhoffmeister assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT markjenkins assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT ulrikepeters assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT lihsu assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT stephenbgruber assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT grahamcasey assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT stephanielschmit assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT tracyaomara assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT amandabspurdle assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT deborahjthompson assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT iantomlinson assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT immaculatadevivo assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT mariateresalandi assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT matthewhlaw assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT markmiles assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT florencedemenais assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT rajivkumar assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT stuartmacgregor assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT dtimothybishop assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT sarahvward assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT melissalbondy assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT richardhoulston assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT johnkwiencke assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT beatricemelin assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT jillbarnholtzsloan assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT benkinnersley assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT margaretrwrensch assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT christopheriamos assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT rayjeanjhung assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT paulbrennan assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT jamesmckay assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT neilecaporaso assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT sonjaiberndt assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT brendambirmann assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT nicolajcamp assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT peterkraft assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT nathanielrothman assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT susanlslager assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT andrewberchuck assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT pauldppharoah assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT thomasasellers assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT simonagayther assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT celestelpearce assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT ellenlgoode assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT joellenmschildkraut assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT kirstenbmoysich assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT laufeytamundadottir assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT ericjjacobs assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT alisonpklein assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT gloriampetersen assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT harveyarisch assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT rachelzstolzenbergsolomon assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT brianmwolpin assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT donghuili assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT rosalindaeeles assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT christopherahaiman assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT zsofiakotejarai assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT fredrickrschumacher assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT aliaminalolama assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT markppurdue assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT ghislainescelo assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT marleneddalgaard assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT markhgreene assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT tomgrotmol assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT peterakanetsky assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT katherineamcglynn assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT katherinelnathanson assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT clareturnbull assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT fredrikwiklund assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT breastcancerassociationconsortiumbcac assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT barrettsandesophagealadenocarcinomaconsortiumbeacon assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT coloncancerfamilyregistryccfr assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT transdisciplinarystudiesofgeneticvariationincolorectalcancercorect assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT endometrialcancerassociationconsortiumecac assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT geneticsandepidemiologyofcolorectalcancerconsortiumgecco assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT melanomageneticsconsortiumgenomel assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT gliomainternationalcasecontrolstudygicc assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT internationallungcancerconsortiumilcco assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT integrativeanalysisoflungcanceretiologyandriskintegralconsortium assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT internationalconsortiumofinvestigatorsworkingonnonhodgkinslymphomaepidemiologicstudiesinterlymph assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT ovariancancerassociationconsortiumocac assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT oralcancergwas assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT pancreaticcancercasecontrolconsortiumpanc4 assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT pancreaticcancercohortconsortiumpanscan assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT prostatecancerassociationgrouptoinvestigatecancerassociatedalterationsinthegenomepractical assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT renalcancergwas assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT testicularcancerconsortiumtecac assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT stephenjchanock assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT nilanjanchatterjee assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers AT montserratgarciaclosas assessmentofpolygenicarchitectureandriskpredictionbasedoncommonvariantsacrossfourteencancers |
_version_ |
1721319910259294208 |
spelling |
doaj-043bfd656ef148a0993f50953c04b25f2021-07-04T11:47:07ZengNature Publishing GroupNature Communications2041-17232020-07-0111111310.1038/s41467-020-16483-3Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancersYan Dora Zhang0Amber N. Hurson1Haoyu Zhang2Parichoy Pal Choudhury3Douglas F. Easton4Roger L. Milne5Jacques Simard6Per Hall7Kyriaki Michailidou8Joe Dennis9Marjanka K. Schmidt10Jenny Chang-Claude11Puya Gharahkhani12David Whiteman13Peter T. Campbell14Michael Hoffmeister15Mark Jenkins16Ulrike Peters17Li Hsu18Stephen B. Gruber19Graham Casey20Stephanie L. Schmit21Tracy A. O’Mara22Amanda B. Spurdle23Deborah J. Thompson24Ian Tomlinson25Immaculata De Vivo26Maria Teresa Landi27Matthew H. Law28Mark M. Iles29Florence Demenais30Rajiv Kumar31Stuart MacGregor32D. Timothy Bishop33Sarah V. Ward34Melissa L. Bondy35Richard Houlston36John K. Wiencke37Beatrice Melin38Jill Barnholtz-Sloan39Ben Kinnersley40Margaret R. Wrensch41Christopher I. Amos42Rayjean J. Hung43Paul Brennan44James McKay45Neil E. Caporaso46Sonja I. Berndt47Brenda M. Birmann48Nicola J. Camp49Peter Kraft50Nathaniel Rothman51Susan L. Slager52Andrew Berchuck53Paul D. P. Pharoah54Thomas A. Sellers55Simon A. Gayther56Celeste L. Pearce57Ellen L. Goode58Joellen M. Schildkraut59Kirsten B. Moysich60Laufey T. Amundadottir61Eric J. Jacobs62Alison P. Klein63Gloria M. Petersen64Harvey A. Risch65Rachel Z. Stolzenberg-Solomon66Brian M. Wolpin67Donghui Li68Rosalind A. Eeles69Christopher A. Haiman70Zsofia Kote-Jarai71Fredrick R. Schumacher72Ali Amin Al Olama73Mark P. Purdue74Ghislaine Scelo75Marlene D. Dalgaard76Mark H. Greene77Tom Grotmol78Peter A. Kanetsky79Katherine A. McGlynn80Katherine L. Nathanson81Clare Turnbull82Fredrik Wiklund83Breast Cancer Association Consortium (BCAC)Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON)Colon Cancer Family Registry (CCFR)Transdisciplinary Studies of Genetic Variation in Colorectal Cancer (CORECT)Endometrial Cancer Association Consortium (ECAC)Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO)Melanoma Genetics Consortium (GenoMEL)Glioma International Case-Control Study (GICC)International Lung Cancer Consortium (ILCCO)Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) ConsortiumInternational Consortium of Investigators Working on Non-Hodgkin’s Lymphoma Epidemiologic Studies (InterLymph)Ovarian Cancer Association Consortium (OCAC)Oral Cancer GWASPancreatic Cancer Case-Control Consortium (PanC4)Pancreatic Cancer Cohort Consortium (PanScan)Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL)Renal Cancer GWASTesticular Cancer Consortium (TECAC)Stephen J. Chanock84Nilanjan Chatterjee85Montserrat Garcia-Closas86Department of Statistics and Actuarial Science, Faculty of Science, The University of Hong KongDivision of Cancer Epidemiology and Genetics, National Cancer InstituteDivision of Cancer Epidemiology and Genetics, National Cancer InstituteDivision of Cancer Epidemiology and Genetics, National Cancer InstituteDepartment of Oncology, Centre for Cancer Genetic Epidemiology, University of CambridgeCancer Epidemiology Division, Cancer Council VictoriaCentre Hospitalier Universitaire de Québec–Université Laval Research CenterDepartment of Medical Epidemiology and Biostatistics, Karolinska InstitutetDepartment of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of CambridgeDepartment of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of CambridgeDivision of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek HospitalDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ)Statistical Genetics, QIMR Berghofer Medical Research InstituteCancer Control, QIMR Berghofer Medical Research InstituteBehavioral and Epidemiology Research Group, American Cancer SocietyDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ)Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of MelbournePublic Health Sciences Division, Fred Hutchinson Cancer Research CenterPublic Health Sciences Division, Fred Hutchinson Cancer Research CenterDepartment of Preventive Medicine, USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern CaliforniaDepartment of Public Health Sciences, Center for Public Health Genomics, University of VirginiaDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research InstitutionGenetics and Computational Biology Division, QIMR Berghofer Medical Research InstituteGenetics and Computational Biology Division, QIMR Berghofer Medical Research InstituteDepartment of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of CambridgeInstitute of Cancer and Genomic Sciences, University of BirminghamChanning Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical SchoolDivision of Cancer Epidemiology and Genetics, National Cancer InstituteStatistical Genetics, QIMR Berghofer Medical Research InstituteSection of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of LeedsUniversité de Paris, UMRS-1124, Institut National de la Santé et de la Recherche Médicale (INSERM)Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ)Statistical Genetics, QIMR Berghofer Medical Research InstituteDivision of Haematology and Immunology, Leeds Institute of Medical Research, University of LeedsCentre for Genetic Origins of Health and Disease, School of Biomedical Sciences, The University of Western AustraliaDepartment of Medicine, Section of Epidemiology and Population Sciences, Baylor College of MedicineDivision of Genetics and Epidemiology, The Institute of Cancer ResearchDepartment of Neurological Surgery, School of Medicine, University of California, San FranciscoDepartment of Radiation Sciences Oncology, Umeå UniversityCase Comprehensive Cancer Center, Case Western Reserve University School of MedicineDivision of Genetics and Epidemiology, The Institute of Cancer ResearchDepartment of Neurological Surgery, School of Medicine, University of California, San FranciscoInstitute for Clinical and Translational Research, Dan L. Duncan Comprehensive Cancer Center, Baylor College of MedicineLunenfeld-Tanenbuaum Research Institute, Sinai Health SystemInternational Agency for Research on Cancer, World Health OrganizationInternational Agency for Research on Cancer, World Health OrganizationDivision of Cancer Epidemiology and Genetics, National Cancer InstituteDivision of Cancer Epidemiology and Genetics, National Cancer InstituteChanning Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical SchoolDivision of Hematology and Hematological Malignancies, University of Utah School of MedicineProgram in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public HealthDivision of Cancer Epidemiology and Genetics, National Cancer InstituteDivision of Biomedical Statistics & Informatics, Department of Health Sciences Research, Mayo ClinicDepartment of Gynecologic Oncology, Duke University Medical CenterDepartment of Oncology, Centre for Cancer Genetic Epidemiology, University of CambridgeDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research InstitutionCenter for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core, Cedars-Sinai Medical CenterDepartment of Preventive Medicine, USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern CaliforniaDivision of Epidemiology, Department of Health Science Research, Mayo ClinicRollins School of Public Health, Emory UniversityDivision of Cancer Prevention and Control, Roswell Park Cancer InstituteLaboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of HealthBehavioral and Epidemiology Research Group, American Cancer SocietyDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of MedicineDivision of Epidemiology, Department of Health Science Research, Mayo ClinicChronic Disease Epidemiology, Yale School of MedicineDivision of Cancer Epidemiology and Genetics, National Cancer InstituteDepartment of Medical Oncology, Dana-Farber Cancer InstituteDivision of Cancer Medicine, GI Medical Oncology Department, The University of Texas MD Anderson Cancer CenterDivision of Genetics and Epidemiology, The Institute of Cancer ResearchDepartment of Preventive Medicine, USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern CaliforniaDivision of Genetics and Epidemiology, The Institute of Cancer ResearchDepartment of Population and Quantitative Health Sciences, Case Western Reserve University School of MedicineStrangeways Research Laboratory, Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of CambridgeDivision of Cancer Epidemiology and Genetics, National Cancer InstituteInternational Agency for Research on Cancer, World Health OrganizationDepartment of Growth and Reproduction, Copenhagen University Hospital (Rigshospitalet)Clinical Genetics Branch, Division of Cancer Genetics and Epidemiology, National Cancer InstituteCancer Registry of NorwayDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research InstitutionDivision of Cancer Epidemiology and Genetics, National Cancer InstituteDivision of Translational Health and Human Genetics, Department of Medicine, University of PennsylvaniaDivision of Genetics and Epidemiology, The Institute of Cancer ResearchDepartment of Medical Epidemiology and Biostatistics, Karolinska InstitutetDivision of Cancer Epidemiology and Genetics, National Cancer InstituteDepartment of Biostatistics, Bloomberg School of Public Health, Johns Hopkins UniversityDivision of Cancer Epidemiology and Genetics, National Cancer InstituteIn cancer many gene variants may contribute to disease etiology, but the impact of a given gene variant may have varied effect size. Here, the authors analyse summary statistics of genome-wide association studies from fourteen cancers, and show the utility of polygenic risk scores may vary depending on cancer type.https://doi.org/10.1038/s41467-020-16483-3 |